NewAmsterdam Pharma Files 8-K on Financials
Ticker: NAMSW · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1936258
| Field | Detail |
|---|---|
| Company | Newamsterdam Pharma CO N.V. (NAMSW) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
NAP filed an 8-K on 2/26/25 detailing financial results. Check it out.
AI Summary
NewAmsterdam Pharma Co N.V. filed an 8-K on February 26, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Naarden, The Netherlands.
Why It Matters
This 8-K filing provides investors with updated information on NewAmsterdam Pharma's financial performance and condition, which is crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) that does not appear to contain any significant new risks or material events.
Key Players & Entities
- NewAmsterdam Pharma Co N.V. (company) — Registrant
- February 26, 2025 (date) — Date of earliest event reported
- Naarden, The Netherlands (location) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of NewAmsterdam Pharma Co N.V., and it includes Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on February 26, 2025.
Where are NewAmsterdam Pharma Co N.V.'s principal executive offices located?
NewAmsterdam Pharma Co N.V.'s principal executive offices are located at Goomieer 2-35, Naarden, The Netherlands, 1411 DC.
What is the Commission File Number for NewAmsterdam Pharma Co N.V.?
The Commission File Number for NewAmsterdam Pharma Co N.V. is 001-41562.
What is the Standard Industrial Classification code for NewAmsterdam Pharma Co N.V.?
The Standard Industrial Classification code for NewAmsterdam Pharma Co N.V. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding NewAmsterdam Pharma Co N.V. (NAMSW).